BeStock  
Stocks › Biotechnology › ODTX

Odyssey Therapeutics ODTX

US equityMarket cap rank #3291Biotechnology
$16.96 −$1.38 (-7.52%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $16.96 0.00%
Open$17.65
Prev close$18.34
Day range$16.46 – $18.08
Volume677.8K
Market cap$815.23M
P/E (TTM)–
Dividend yield–

ODTX Stock News

Headlines matching Odyssey Therapeutics or the ODTX ticker, most recent first.

  • H.C. Wainwright Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $44Market news · 22 Sep 2026 · Direct mention
  • H.C. Wainwright Keeps Their Buy Rating on Odyssey Therapeutics, Inc. (ODTX)TipRanks · 22 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)TipRanks · 6 Aug 2026 · Direct mention
  • Wedbush Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $30Market news · 6 Aug 2026 · Direct mention
  • H.C. Wainwright Initiates Odyssey Therapeutics(ODTX.US) With Buy Rating, Announces Target Price $44Market news · 27 Aug 2026 · Direct mention
  • TD Cowen Maintains Odyssey Therapeutics(ODTX.US) With Buy RatingMarket news · 12 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (ODTX), Metagenomi, Inc. (MGX) and Autolus Therapeutics (AUTL)TipRanks · 12 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Raises Target Price to $29 PositiveMarket news · 11 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Odyssey Therapeutics(ODTX.US), With a Forecast Between $16.96 to $40Market news · 3 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (ODTX), Capricor Therapeutics (CAPR) and Medtronic (MDT)TipRanks · 18 Jun 2026 · Direct mention
  • Oppenheimer Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $40Market news · 18 Jun 2026 · Direct mention
  • H.C. Wainwright Initiates Odyssey Therapeutics(ODTX.US) With Buy Rating, Announces Target Price $40Market news · 6 Nov 2026 · Direct mention
  • Wedbush Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $30Market news · 6 Nov 2026 · Direct mention
  • Oppenheimer Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $40Market news · 22 Oct 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Odyssey Therapeutics, Inc. (ODTX)TipRanks · 22 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ODTX.

Sign in to join the discussion.

Scroll to Top